<DOC>
	<DOC>NCT00300755</DOC>
	<brief_summary>To evaluate the clinical outcomes of treatment with oral pantoprazole in children 1 through 5 years of age with endoscopically proven symptomatic GERD.</brief_summary>
	<brief_title>Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Ability to undergo endoscopy with required biopsy Ages 1 through 5 years Endoscopically confirmed GERD by positive endoscopic evidence of reflux related esophagitis or positive histologic evidence of esophagitis consistent with GERD Other inclusions apply. History or presence of upper gastrointestinal anatomic or motor disorders Known current or active cow`s milk allergy Malignancy Other exclusions apply.</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>GERD</keyword>
	<keyword>Children</keyword>
	<keyword>Child</keyword>
	<keyword>Child, Preschool</keyword>
</DOC>